Can we tailor neoadjuvant (primary) systemic therapy for breast cancer? | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.09.2008 | Short review

Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?

verfasst von: A. Eniu

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer

Nächster Artikel Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

Titel: Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
verfasst von: A. Eniu
Publikationsdatum: 01.09.2008
Verlag: Springer-Verlag
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 3/2008
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-008-0050-1

Weitere Artikel der Ausgabe 3/2008

Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients

Short review

"Old tricks and new procedures" – a report from the 34th Annual Meeting of the European Group for Blood and Marrow Transplantation EBMT, March 30 – April 2, 2008, Florence, Italy

Congress report

CECOG at ASCO 2008

CECOG News

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer: a case presentation

Case report

Treatment options in localised and metastatic renal cell carcinoma

Short review

Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

Review